Travere Therapeutics, Inc.   Report issue

For profit Phase 2
Founded: San Diego CA United States (2011)

Organization Overview

First Clinical Trial
2020
NCT04663204
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Travere Therapeutics, Inc.